Benzene, 1-bromo-4-(bromomethyl)-2,5-difluoro-(486460-10-0)
- Name: Benzene, 1-bromo-4-(bromomethyl)-2,5-difluoro-
- Synonyms:
- Molecular Formula:C7H4Br2F2
- Molecular Weight:285.914
- CAS Registry Number:486460-10-0
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.486460-10-0 1-Bromo-4-(Bromomethyl)-2, 5-Difluorobenzene
Assay:98% Appearance:White Powder Package:25/kg?paper?drum?and?double?plastic?food bags?inside. Storage:Keep it in dry, cool and ventilated place Transportation:By sea or by air Application:Pharmaceutical Intermediate
Min. Order:1Metric Ton
Supplier:COLORCOM LTD. [
China (Mainland)] CAS No.486460-10-0 1-bromo-4-(bromomethyl)-2,5-difluorobenzene
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)] CAS No.486460-10-0 Benzene, 1-bromo-4-(bromomethyl)-2,5-difluoro-
Assay:99% Package:box or opp package Storage:cool drum Transportation:air or sea Application:Benzene, 1-bromo-4-(bromomethyl)-2,5-difluoro-
Min. Order:1Milligram
Supplier:weifang yangxu group co.,ltd [
China (Mainland)]
Other Product
- 486459-71-6/Sitagliptin monohydrochloride
- 486459-74-9/Imidazo[1,2-a]pyrazine, 7-[(3R)-3-amino-4-(2-fluorophenyl)-1-oxobutyl]-5,6,7,8-tetrahydro-
- 486459-76-1/Imidazo[1,2-a]pyrazine, 7-[(3R)-3-amino-4-(3,4-difluorophenyl)-1-oxobutyl]-2-(4-fluorophenyl)-5, 6,7,8-tetrahydro-
- 486459-77-2/Imidazo[1,2-a]pyrazine, 7-[(3R)-3-amino-4-(3,4-difluorophenyl)-1-oxobutyl]-5,6,7,8-tetrahydro-2- phenyl-
- 486459-78-3/Imidazo[1,2-a]pyrazine, 7-[(3R)-3-amino-4-(3,4-difluorophenyl)-1-oxobutyl]-5,6,7,8-tetrahydro-2- (4-methoxyphenyl)-
- 486459-79-4/Imidazo[1,2-a]pyrazine, 7-[(3R)-3-amino-4-(3,4-difluorophenyl)-1-oxobutyl]-2-(3,4-difluorophenyl )-5,6,7,8-tetrahydro-
- 486459-80-7/Imidazo[1,2-a]pyrazine, 7-[(3R)-3-amino-4-(3,4-difluorophenyl)-1-oxobutyl]-5,6,7,8-tetrahydro-2- [4-(trifluoromethoxy)phenyl]-
- 486459-81-8/Imidazo[1,2-a]pyrazine, 7-[(3R)-3-amino-4-(3,4-difluorophenyl)-1-oxobutyl]-5,6,7,8-tetrahydro-2- (pentafluoroethyl)-
- 486459-86-3/1,2,4-Triazolo[4,3-a]pyrazine, 7-[(3R)-3-amino-4-(2-fluorophenyl)-1-oxobutyl]-5,6,7,8-tetrahydro-
- 486459-87-4/1,2,4-Triazolo[4,3-a]pyrazine, 7-[(3R)-3-amino-4-(3,4-difluorophenyl)-1-oxobutyl]-5,6,7,8-tetrahydro-
- 486459-88-5/1,2,4-Triazolo[4,3-a]pyrazine, 7-[(3R)-3-amino-4-(3,4-difluorophenyl)-1-oxobutyl]-5,6,7,8-tetrahydro-3- (trifluoromethyl)-
- 486459-89-6/1,2,4-Triazolo[4,3-a]pyrazine, 7-[(3R)-3-amino-4-[2-fluoro-4-(trifluoromethyl)phenyl]-1-oxobutyl]-5,6,7,8 -tetrahydro-3-(trifluoromethyl)-
- 486459-94-3/Imidazo[1,2-a]pyrazine, 7-[(3R)-3-amino-4-[2-fluoro-4-(trifluoromethyl)phenyl]-1-oxobutyl]-5,6,7,8 -tetrahydro-2-(trifluoromethyl)-
- 486459-95-4/Imidazo[1,2-a]pyrazine, 7-[(3R)-3-amino-1-oxo-4-(2,4,5-trifluorophenyl)butyl]-5,6,7,8-tetrahydro- 2-(pentafluoroethyl)-
- 486460-02-0/Phenylalanine, N-[(1,1-dimethylethoxy)carbonyl]-2,5-difluoro-
- 486460-03-1/Carbamic acid, [3-diazo-1-[(2,5-difluorophenyl)methyl]-2-oxopropyl]-, 1,1-dimethylethyl ester
- 486460-04-2/Pyrazine, 2-[[2-fluoro-4-(trifluoromethyl)phenyl]methyl]-2,5-dihydro-3,6-dimethoxy- 5-(1-methylethyl)-, (2R,5S)-
- 486460-05-3/D-Phenylalanine, N-[(1,1-dimethylethoxy)carbonyl]-2-fluoro-4-(trifluoromethyl)-, methyl ester
- 486460-06-4/D-Phenylalanine, N-[(1,1-dimethylethoxy)carbonyl]-2-fluoro-4-(trifluoromethyl)-
- 486460-10-0/Benzene, 1-bromo-4-(bromomethyl)-2,5-difluoro-
- 486460-11-1/Pyrazine, 2-[(4-bromo-2,5-difluorophenyl)methyl]-2,5-dihydro-3,6-dimethoxy-5-(1- methylethyl)-, (2R,5S)-
- 486460-12-2/D-Phenylalanine, 4-bromo-N-[(1,1-dimethylethoxy)carbonyl]-2,5-difluoro-, methyl ester
- 486460-13-3/D-Phenylalanine, 4-bromo-N-[(1,1-dimethylethoxy)carbonyl]-2,5-difluoro-
- 486460-16-6/Carbamic acid, [(1R)-3-[5,6-dihydro-2-(trifluoromethyl)imidazo[1,2-a]pyrazin-7(8H)-yl]-3 -oxo-1-[(2,4,5-trifluorophenyl)methyl]propyl]-, 1,1-dimethylethyl ester
- 486460-17-7/Carbamic acid, [(1R)-1-[(3,4-difluorophenyl)methyl]-3-(5,6-dihydroimidazo[1,2-a]pyrazin -7(8H)-yl)-3-oxopropyl]-, 1,1-dimethylethyl ester
- 486460-19-9/Carbamic acid, [(1R)-1-[(3,4-difluorophenyl)methyl]-3-(3-ethyl-5,6-dihydro-1,2,4-triazolo[ 4,3-a]pyrazin-7(8H)-yl)-3-oxopropyl]-, 1,1-dimethylethyl ester
- 486460-22-4/Carbamic acid, [(1R)-1-[(2,5-difluorophenyl)methyl]-3-[5,6-dihydro-3-(trifluoromethyl)-1,2 ,4-triazolo[4,3-a]pyrazin-7(8H)-yl]-3-oxopropyl]-, 1,1-dimethylethyl ester
- 486460-23-5/Sitagliptin N-Boc IMpurity
- 486460-24-6/Carbamic acid, [(1R)-3-diazo-1-[[2-fluoro-4-(trifluoromethyl)phenyl]methyl]-2-oxopropyl]-, 1,1-dimethylethyl ester
- 486460-25-7/Carbamic acid, [(1R)-3-diazo-2-oxo-1-[(2,4,5-trifluorophenyl)methyl]propyl]-, 1,1-dimethylethyl ester